Trials / Completed
CompletedNCT01199042
Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients
BiPAP (Automatic Servo Ventilation) autoSV Advanced in Central Apnea Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Philips Respironics · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Pilot study testing the Bipap autoSV Advanced Algorithm during full night, in-lab polysomnography (PSG) and 3 months at home on patients with Central Sleep Apnea, Hunter Cheyne Stokes Respiration, or Complex Sleep Apnea.
Detailed description
Participants who qualify will be scheduled for one full night, attended diagnostic PSG, one full night attended continuous positive airway pressure (CPAP) titration, and one full night attended BiPAP autoSV Advanced titration PSG. Participants will be provided a BiPAP autoSV Advanced to use at home for 90 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BiPAP autoSV Advanced | The sleep apnea device will be set-up in automatic mode with the settings wide open for the entire night. |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2010-09-10
- Last updated
- 2016-04-28
- Results posted
- 2016-04-28
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01199042. Inclusion in this directory is not an endorsement.